{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T07:57:08Z","timestamp":1773993428629,"version":"3.50.1"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T00:00:00Z","timestamp":1598227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T00:00:00Z","timestamp":1598227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2018\/20775-0"],"award-info":[{"award-number":["2018\/20775-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2014\/13663-0"],"award-info":[{"award-number":["2014\/13663-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2018\/04254-0"],"award-info":[{"award-number":["2018\/04254-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2019\/06076-5"],"award-info":[{"award-number":["2019\/06076-5"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2017\/18344-9"],"award-info":[{"award-number":["2017\/18344-9"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2018\/15553-9"],"award-info":[{"award-number":["2018\/15553-9"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>We have previously developed a murine cellular system that models the transformation from melanocytes to metastatic melanoma cells. This model was established by cycles of anchorage impediment of melanocytes and consists of four cell lines: differentiated melanocytes (melan-a), pre-malignant melanocytes (4C), malignant (4C11\u2212), and metastasis-prone (4C11+) melanoma cells. Here, we searched for transcriptional and epigenetic signatures associated with melanoma progression and metastasis by performing a gene co-expression analysis of transcriptome data and a mass-spectrometry-based profiling of histone modifications in this model.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Eighteen modules of co-expressed genes were identified, and some of them were associated with melanoma progression, epithelial-to-mesenchymal transition (EMT), and metastasis. The genes in these modules participate in biological processes like focal adhesion, cell migration, extracellular matrix organization, endocytosis, cell cycle, DNA repair, protein ubiquitination, and autophagy. Modules and hub signatures related to EMT and metastasis (turquoise, green yellow, and yellow) were significantly enriched in genes associated to patient survival in two independent melanoma cohorts (TCGA and Leeds), suggesting they could be sources of novel prognostic biomarkers. Clusters of histone modifications were also linked to melanoma progression, EMT, and metastasis. Reduced levels of H4K5ac and H4K8ac marks were seen in the pre-malignant and tumorigenic cell lines, whereas the methylation patterns of H3K4, H3K56, and H4K20 were related to EMT. Moreover, the metastatic 4C11+ cell line showed higher H3K9me2 and H3K36me3 methylation, lower H3K18me1, H3K23me1, H3K79me2, and H3K36me2 marks and, in agreement, downregulation of the H3K36me2 methyltransferase Nsd1.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We uncovered transcriptional and histone modification signatures that may be molecular events driving melanoma progression and metastasis, which can aid in the identification of novel prognostic genes and drug targets for treating the disease.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13148-020-00910-9","type":"journal-article","created":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T10:03:45Z","timestamp":1598263425000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Gene co-expression and histone modification signatures are associated with melanoma progression, epithelial-to-mesenchymal transition, and metastasis"],"prefix":"10.1186","volume":"12","author":[{"given":"H\u00e1tylas","family":"Azevedo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guilherme Cavalcante","family":"Pessoa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisca Nath\u00e1lia","family":"de Luna Vitorino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9r\u00e9mie","family":"Nsengimana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Newton-Bishop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo Moraes","family":"Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00falia Pinheiro Chagas","family":"da Cunha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4135-0440","authenticated-orcid":false,"given":"Miriam Galvonas","family":"Jasiulionis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,24]]},"reference":[{"key":"910_CR1","unstructured":"American Cancer Society. Cancer facts & figures. Atlanta, Ga: American Cancer Society. 2020."},{"key":"910_CR2","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.bbcan.2019.02.002","volume":"1871","author":"I Kozar","year":"2019","unstructured":"Kozar I, Margue C, Rothengatter S, Haan C, Kreis S. Many ways to resistance: how melanoma cells evade targeted therapies. Biochim Biophys Acta Rev Cancer. 2019;1871:313\u201322.","journal-title":"Biochim Biophys Acta Rev Cancer."},{"key":"910_CR3","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S0046-8177(84)80310-X","volume":"15","author":"WH Clark Jr","year":"1984","unstructured":"Clark WH Jr, Elder DE, Guerry D, Epstein MN, Greene MH, Van Horn M. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum Pathol. 1984;15:1147\u201365.","journal-title":"Hum Pathol."},{"key":"910_CR4","first-page":"1071","volume":"52","author":"GC Leonardi","year":"2018","unstructured":"Leonardi GC, Falzone L, Salemi R, Zangh\u00ec A, Spandidos DA, Mccubrey JA, et al. Cutaneous melanoma: from pathogenesis to therapy (Review). Int J Oncol. 2018;52:1071\u201380.","journal-title":"Int J Oncol."},{"key":"910_CR5","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13148-018-0583-z","volume":"10","author":"E Orouji","year":"2018","unstructured":"Orouji E, Utikal J. Tackling malignant melanoma epigenetically: histone lysine methylation. Clin Epigenetics. 2018;10:145.","journal-title":"Clin Epigenetics."},{"key":"910_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2017.11","volume":"49","author":"K Hyun","year":"2017","unstructured":"Hyun K, Jeon J, Park K, Kim J. Writing, erasing and reading histone lysine methylations. Exp Mol Med. 2017;49:e324.","journal-title":"Exp Mol Med."},{"key":"910_CR7","doi-asserted-by":"crossref","unstructured":"Gallagher SJ, Tiffen JC, Hersey P. Histone modifications, modifiers and readers in melanoma resistance to targeted and immune therapy. Cancers (Basel). 2015; 7: 1959\u20131982.","DOI":"10.3390\/cancers7040870"},{"key":"910_CR8","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.3390\/cells8091034","volume":"8","author":"AA Igolkina","year":"2019","unstructured":"Igolkina AA, Zinkevich A, Karandasheva KO, Popov AA, Selifanova MV, Nikolaeva D, et al. H3K4me3, H3K9ac, H3K27ac, H3K27me3 and H3K9me3 histone tags suggest distinct regulatory evolution of open and condensed chromatin landmarks. Cells. 2019;8:1034.","journal-title":"Cells"},{"key":"910_CR9","doi-asserted-by":"publisher","first-page":"450","DOI":"10.4161\/epi.6.4.14917","volume":"6","author":"F Molognoni","year":"2011","unstructured":"Molognoni F, Cruz AT, Meliso FM, Morais AS, Souza CF, Xander P, et al. Epigenetic reprogramming as a key contributor to melanocyte malignant transformation. Epigenetics. 2011;6:450\u201364.","journal-title":"Epigenetics."},{"key":"910_CR10","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1593\/neo.05781","volume":"8","author":"SM Oba-Shinjo","year":"2006","unstructured":"Oba-Shinjo SM, Correa M, Ricca TI, Molognoni F, Pinhal MA, Neves IA, et al. Melanocyte transformation associated with substrate adhesion impediment. Neoplasia. 2006;8:231\u201341.","journal-title":"Neoplasia."},{"key":"910_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044800","volume":"7","author":"CF de Souza","year":"2012","unstructured":"de Souza CF, Xander P, Monteiro AC, Silva AG, da Silva DC, Mai S, et al. Mining gene expression signature for the detection of pre-malignant melanocytes and early melanomas with risk for metastasis. PLoS One. 2012;7:e44800.","journal-title":"PLoS One."},{"key":"910_CR12","unstructured":"Pessoa DO, Rius FE, Papaiz D, Auyb AL, Morais AS, de Souza CF, et al. The global transcriptome analysis of a murine model of melanoma initiation and progression unravels independent prognostic factors for melanoma patients. 2020. Manuscript submitted."},{"key":"910_CR13","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.biosystems.2013.06.003","volume":"113","author":"K Takemoto","year":"2013","unstructured":"Takemoto K, Kihara K. Modular organization of cancer signaling networks is associated with patient survivability. Biosystems. 2013;113:149\u201354.","journal-title":"Biosystems."},{"key":"910_CR14","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/978-94-007-4819-4_15","volume":"2012","author":"A Nath","year":"2012","unstructured":"Nath A, Chan C. Relevance of network hierarchy in cancer drug-target selection. Systems Biology in Cancer Research and Drug Discovery. 2012;2012:339\u201362.","journal-title":"Systems Biology in Cancer Research and Drug Discovery."},{"key":"910_CR15","doi-asserted-by":"publisher","first-page":"6827","DOI":"10.2147\/OTT.S177639","volume":"11","author":"EM O'Day","year":"2018","unstructured":"O'Day EM, Idos GE, Hill C, Chen JW, Wagner G. Cytidine monophosphate N-acetylneuraminic acid synthetase enhances invasion of human triple-negative breast cancer cells. Onco Targets Ther. 2018;11:6827\u201338.","journal-title":"Onco Targets Ther."},{"key":"910_CR16","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20180770","volume":"38","author":"LF Sembajwe","year":"2018","unstructured":"Sembajwe LF, Katta K, Gr\u00f8nning M, Kusche-Gullberg M. The exostosin family of glycosyltransferases: mRNA expression profiles and heparan sulphate structure in human breast carcinoma cell lines. Biosci Rep. 2018;38:BSR20180770.","journal-title":"Biosci Rep."},{"key":"910_CR17","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1158\/1535-7163.MCT-19-0150","volume":"18","author":"S Umbreen","year":"2019","unstructured":"Umbreen S, Banday MM, Jamroze A, Mansini AP, Ganaie AA, Ferrari MG, et al. COMMD3:BMI1 fusion and COMMD3 protein regulate C-MYC transcription: novel therapeutic target for metastatic prostate cancer. Mol Cancer Ther. 2019;18:2111\u201323.","journal-title":"Mol Cancer Ther."},{"key":"910_CR18","first-page":"721","volume":"28","author":"AE Denk","year":"2011","unstructured":"Denk AE, Braig S, Schubert T, Bosserhoff AK. Slit3 inhibits activator protein 1-mediated migration of malignant melanoma cells. Int J Mol Med. 2011;28:721\u20136.","journal-title":"Int J Mol Med."},{"key":"910_CR19","doi-asserted-by":"publisher","first-page":"9083","DOI":"10.1038\/srep09083","volume":"5","author":"R Hata","year":"2015","unstructured":"Hata R, Izukuri K, Kato Y, Sasaki S, Mukaida N, Maehata Y, et al. Suppressed rate of carcinogenesis and decreases in tumour volume and lung metastasis in CXCL14\/BRAK transgenic mice. Sci Rep. 2015;5:9083.","journal-title":"Sci Rep."},{"key":"910_CR20","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s12307-012-0105-z","volume":"5","author":"Q Xiao","year":"2012","unstructured":"Xiao Q, Ge G. Lysyl oxidase, extracellular matrix remodeling and cancer metastasis. Cancer Microenviron. 2012;5:261\u201373.","journal-title":"Cancer Microenviron."},{"key":"910_CR21","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.1038\/onc.2011.85","volume":"30","author":"YY Wu","year":"2011","unstructured":"Wu YY, Peck K, Chang YL, Pan SH, Cheng YF, Lin JC, et al. SCUBE3 is an endogenous TGF-\u03b2 receptor ligand and regulates the epithelial-mesenchymal transition in lung cancer. Oncogene. 2011;30:3682\u201393.","journal-title":"Oncogene."},{"key":"910_CR22","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1113\/EP086839","volume":"103","author":"M Tan","year":"2018","unstructured":"Tan M, Liu C, Huang W, Deng L, Qin X, Xiang Y. CTNNAL1 inhibits ozone-induced epithelial-mesenchymal transition in human bronchial epithelial cells. Exp Physiol. 2018;103:1157\u201369.","journal-title":"Exp Physiol."},{"key":"910_CR23","doi-asserted-by":"publisher","first-page":"7793","DOI":"10.1002\/cam4.2639","volume":"8","author":"Z Dong","year":"2019","unstructured":"Dong Z, Zou J, Li J, Pang Y, Liu Y, Deng C, et al. MYST1\/KAT8 contributes to tumor progression by activating EGFR signaling in glioblastoma cells. Cancer Med. 2019;8:7793\u2013808.","journal-title":"Cancer Med."},{"key":"910_CR24","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.celrep.2013.06.013","volume":"4","author":"H Garcia","year":"2013","unstructured":"Garcia H, Miecznikowski JC, Safina A, Commane M, Ruusulehto A, Kilpinen S, et al. Facilitates chromatin transcription complex is an \u201caccelerator\u201d of tumor transformation and potential marker and target of aggressive cancers. Cell Rep. 2013;4:159\u201373.","journal-title":"Cell Rep."},{"key":"910_CR25","first-page":"649","volume":"20","author":"J Li","year":"2014","unstructured":"Li J, Cui Y, Wang Q, Guo D, Pan X, Wang X, et al. The proliferation of malignant melanoma cells could be inhibited by ranibizumab via antagonizing VEGF through VEGFR1. Mol Vis. 2014;20:649\u201360.","journal-title":"Mol Vis."},{"key":"910_CR26","doi-asserted-by":"crossref","unstructured":"Bartolom\u00e9 RA, Torres S, Isern de Val S, Escudero-Paniagua B, Calvi\u00f1o E, Teixid\u00f3 J, et al. (2017) VE-cadherin RGD motifs promote metastasis and constitute a potential therapeutic target in melanoma and breast cancers. Oncotarget. 2017; 8: 215-227.","DOI":"10.18632\/oncotarget.13832"},{"key":"910_CR27","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12943-015-0446-6","volume":"14","author":"R Kohnken","year":"2015","unstructured":"Kohnken R, Kodigepalli KM, Wu L. Regulation of deoxynucleotide metabolism in cancer: novel mechanisms and therapeutic implications. Mol Cancer. 2015;14:176.","journal-title":"Mol Cancer."},{"key":"910_CR28","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2016.1151593","volume":"5","author":"GM Rodriguez","year":"2016","unstructured":"Rodriguez GM, Bobbala D, Serrano D, Mayhue M, Champagne A, Saucier C, et al. NLRC5 elicits antitumor immunity by enhancing processing and presentation of tumor antigens to CD8(+) T lymphocytes. Oncoimmunology. 2016;5:e1151593.","journal-title":"Oncoimmunology."},{"key":"910_CR29","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1089\/jir.2010.0134","volume":"31","author":"R Scott","year":"2011","unstructured":"Scott R, Siegrist F, Foser S, Certa U. Interferon-alpha induces reversible DNA demethylation of the interferon-induced transmembrane protein-3 core promoter in human melanoma cells. J Interferon Cytokine Res. 2011;31:601\u20138.","journal-title":"J Interferon Cytokine Res."},{"key":"910_CR30","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1158\/2326-6066.CIR-18-0711","volume":"7","author":"L Shao","year":"2019","unstructured":"Shao L, Hou W, Scharping NE, Vendetti FP, Srivastava R, Roy CN, et al. IRF1 inhibits antitumor immunity through the upregulation of PD-L1 in the tumor cell. Cancer Immunol Res. 2019;7:1258\u201366.","journal-title":"Cancer Immunol Res."},{"key":"910_CR31","doi-asserted-by":"crossref","unstructured":"D\u2019 Eletto M, Risuglia A, Oliverio S, Mehdawy B, Nardacci R, Bordi M, et al. Modulation of autophagy by RTN-1C: role in autophagosome biogenesis. Cell Death Dis. 2019; 10: 868.","DOI":"10.1038\/s41419-019-2099-7"},{"key":"910_CR32","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1111\/j.1600-0625.2012.01565.x","volume":"21","author":"H Guo","year":"2012","unstructured":"Guo H, Carlson JA, Slominski A. Role of TRPM in melanocytes and melanoma. Exp Dermatol. 2012;21:650\u20134.","journal-title":"Exp Dermatol."},{"key":"910_CR33","doi-asserted-by":"publisher","first-page":"W556","DOI":"10.1093\/nar\/gkz430","volume":"47","author":"Z Tang","year":"2019","unstructured":"Tang Z, Kang B, Li C, Chen T, Zhang Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47:W556\u201360.","journal-title":"Nucleic Acids Res."},{"key":"910_CR34","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.2353\/ajpath.2009.080543","volume":"174","author":"B Horst","year":"2009","unstructured":"Horst B, Gruvberger-Saal SK, Hopkins BD, Bordone L, Yang Y, Chernoff KA, et al. Gab2-mediated signaling promotes melanoma metastasis. Am J Pathol. 2009;174:1524\u201333.","journal-title":"Am J Pathol."},{"key":"910_CR35","doi-asserted-by":"publisher","first-page":"114540","DOI":"10.18632\/oncotarget.21457","volume":"8","author":"FM Meliso","year":"2017","unstructured":"Meliso FM, Micali D, Silva CT, Sabedot TS, Coetzee SG, Koch A, et al. SIRT1 regulates Mxd1 during malignant melanoma progression. Oncotarget. 2017;8:114540\u201353.","journal-title":"Oncotarget."},{"key":"910_CR36","first-page":"4","volume":"18","author":"Y Wei","year":"2015","unstructured":"Wei Y, An Z, Zou Z, Sumpter R, Su M, Zang X, et al. The stress-responsive kinases MAPKAPK2\/MAPKAPK3 activate starvation-induced autophagy through Beclin 1 phosphorylation. Elife. 2015;18:4.","journal-title":"Elife."},{"key":"910_CR37","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.bbrc.2019.06.047","volume":"516","author":"DK Moon","year":"2019","unstructured":"Moon DK, Bae YJ, Jeong GR, Cho CH, Hwang SC. Upregulated TTYH2 expression is critical for the invasion and migration of U2OS human osteosarcoma cell lines. Biochem Biophys Res Commun. 2019;516:521\u20135.","journal-title":"Biochem Biophys Res Commun."},{"key":"910_CR38","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1158\/1541-7786.MCR-17-0010","volume":"15","author":"AE Gillen","year":"2017","unstructured":"Gillen AE, Brechbuhl HM, Yamamoto TM, Kline E, Pillai MM, Hesselberth JR, et al. Alternative polyadenylation of PRELID1 regulates mitochondrial ROS signaling and cancer outcomes. Mol Cancer Res. 2017;15:1741\u201351.","journal-title":"Mol Cancer Res."},{"key":"910_CR39","doi-asserted-by":"publisher","first-page":"10658","DOI":"10.1073\/pnas.1220748110","volume":"110","author":"L Rochin","year":"2013","unstructured":"Rochin L, Hurbain I, Serneels L, Fort C, Watt B, Leblanc P, et al. BACE2 processes PMEL to form the melanosome amyloid matrix in pigment cells. Proc Natl Acad Sci. 2013;110:10658\u201363.","journal-title":"Proc Natl Acad Sci."},{"key":"910_CR40","doi-asserted-by":"crossref","unstructured":"Zingg D, Debbache J, Pe\u00f1a-Hern\u00e1ndez R, et al. EZH2-mediated primary cilium deconstruction drives metastatic melanoma formation. Cancer Cell. 2018; 34: 69-84.e14.","DOI":"10.1016\/j.ccell.2018.06.001"},{"key":"910_CR41","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1517\/14728220802607363","volume":"13","author":"L Pasini","year":"2009","unstructured":"Pasini L, Turco MY, Luzi L, Aladowicz E, Fagiani E, Lanfrancone L. Melanoma: targeting signaling pathways and RaLP. Expert Opin Ther Targets. 2009;13:93\u2013104.","journal-title":"Expert Opin Ther Targets."},{"key":"910_CR42","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1038\/s41467-017-01642-w","volume":"8","author":"J Carreras-Puigvert","year":"2017","unstructured":"Carreras-Puigvert J, Zitnik M, Jemth AS, Carter M, Unterlass JE, Hallstr\u00f6m B, et al. A comprehensive structural, biochemical and biological profiling of the human NUDIX hydrolase family. Nat Commun. 2017;8:1541.","journal-title":"Nat Commun."},{"key":"910_CR43","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.4161\/cc.10.20.17742","volume":"10","author":"BB Chen","year":"2011","unstructured":"Chen BB, Glasser JR, Coon TA. Mallampalli RK FBXL2 is a ubiquitin E3 ligase subunit that triggers mitotic arrest. Cell Cycle. 2011;10:3487\u201394.","journal-title":"Cell Cycle."},{"key":"910_CR44","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/1878-0261.12161","volume":"12","author":"V-HM Del Castillo","year":"2018","unstructured":"Del Castillo V-HM, van der Weyden L, Nsengimana J, Speak AO, Sj\u00f6berg MK, Bishop DT, et al. Comparative genomics reveals that loss of lunatic fringe (LFNG) promotes melanoma metastasis. Mol Oncol. 2018;12:239\u201355.","journal-title":"Mol Oncol"},{"key":"910_CR45","doi-asserted-by":"publisher","first-page":"18036","DOI":"10.1038\/s41598-018-36173-x","volume":"8","author":"Y Dunkel","year":"2018","unstructured":"Dunkel Y, Reid AL, Ear J, Aznar N, Millward M, Gray E, et al. Prognostic relevance of CCDC88C transcripts in the peripheral blood of patients with cutaneous melanoma. Sci Rep. 2018;8:18036.","journal-title":"Sci Rep."},{"key":"910_CR46","doi-asserted-by":"publisher","first-page":"113766","DOI":"10.18632\/oncotarget.22667","volume":"8","author":"SP Huang","year":"2017","unstructured":"Huang SP, Chang YC, Low QH, Wu ATH, Chen CL, Lin YF, et al. BICD1 expression, as a potential biomarker for prognosis and predicting response to therapy in patients with glioblastomas. Oncotarget. 2017;8:113766\u201391.","journal-title":"Oncotarget"},{"key":"910_CR47","doi-asserted-by":"publisher","first-page":"11207","DOI":"10.2147\/OTT.S226119","volume":"12","author":"TT Wu","year":"2019","unstructured":"Wu TT, Cai J, Tian YH, Chen JF, Cheng ZL, Pu CS, et al. (2019b) MTF2 induces epithelial-mesenchymal transition and progression of hepatocellular carcinoma by transcriptionally activating Snail. Onco Targets Ther. 2019b;12:11207\u201320.","journal-title":"Onco Targets Ther."},{"key":"910_CR48","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1038\/s41388-019-1081-2","volume":"39","author":"A Nihan Kilinc","year":"2020","unstructured":"Nihan Kilinc A, Sugiyama N, Reddy Kalathur RK, Antoniadis H, Birogul H, Ishay-Ronen D, et al. Histone deacetylases, Mbd3\/NuRD, and Tet2 hydroxylase are crucial regulators of epithelial-mesenchymal plasticity and tumor metastasis. Oncogene. 2020;39:1498\u2013513.","journal-title":"Oncogene."},{"key":"910_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.285","volume":"8","author":"C Zhang","year":"2017","unstructured":"Zhang C, Song C, Liu T, Tang R, Chen M, Gao F, et al. KMT2A promotes melanoma cell growth by targeting hTERT signaling pathway. Cell Death Dis. 2017;8:e2940.","journal-title":"Cell Death Dis."},{"key":"910_CR50","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jaad.2018.07.028","volume":"80","author":"BR Gastman","year":"2019","unstructured":"Gastman BR, Gerami P, Kurley SJ, Cook RW, Leachman S, Vetto JT. Identification of patients at risk of metastasis using a prognostic 31-gene expression profile in subpopulations of melanoma patients with favorable outcomes by standard criteria. J Am Acad Dermatol. 2019;80:149\u201357.","journal-title":"J Am Acad Dermatol."},{"key":"910_CR51","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1002\/cam4.1069","volume":"6","author":"J Ma","year":"2017","unstructured":"Ma J, Guo W, Li C. Ubiquitination in melanoma pathogenesis and treatment. Cancer Med. 2017;6:1362\u201377.","journal-title":"Cancer Med."},{"key":"910_CR52","doi-asserted-by":"crossref","unstructured":"Ndoye A, Weeraratna AT. Autophagy- an emerging target for melanoma therapy. 2016; F1000Res 5. pii: F1000 Faculty Rev-1888.","DOI":"10.12688\/f1000research.8347.1"},{"key":"910_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0190447","volume":"13","author":"LX Wang","year":"2018","unstructured":"Wang LX, Li Y, Chen GZ. Network-based co-expression analysis for exploring the potential diagnostic biomarkers of metastatic melanoma. PLoS One. 2018;13:e0190447.","journal-title":"PLoS One."},{"key":"910_CR54","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.biopha.2018.12.135","volume":"111","author":"HZ Wang","year":"2019","unstructured":"Wang HZ, Wang F, Chen PF, Zhang M, Yu MX, Wang HL, et al. Coexpression network analysis identified that plakophilin 1 is associated with the metastasis in human melanoma. Biomed Pharmacother. 2019;111:1234\u201342.","journal-title":"Biomed Pharmacother."},{"key":"910_CR55","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1016\/j.celrep.2013.11.034","volume":"5","author":"S Javaid","year":"2013","unstructured":"Javaid S, Zhang J, Anderssen E, Black JC, Wittner BS, Tajima K, et al. Dynamic chromatin modification sustains epithelial-mesenchymal transition following inducible expression of Snail-1. Cell Rep. 2013;5:1679\u201389.","journal-title":"Cell Rep."},{"key":"910_CR56","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.celrep.2017.03.078","volume":"19","author":"P Fiziev","year":"2017","unstructured":"Fiziev P, Akdemir KC, Miller JP, Keung EZ, Samant NS, Sharma S, et al. Systematic epigenomic analysis reveals chromatin states associated with melanoma progression. Cell Rep. 2017;19:875\u201389.","journal-title":"Cell Rep."},{"key":"910_CR57","doi-asserted-by":"publisher","first-page":"28553","DOI":"10.1074\/jbc.M110.149393","volume":"285","author":"RK Vempati","year":"2010","unstructured":"Vempati RK, Jayani RS, Notani D, Sengupta A, Galande S, Haldar D, et al. p300-mediated acetylation of histone H3 lysine 56 functions in DNA damage response in mammals. J Biol Chem. 2010;285:28553\u201364.","journal-title":"J Biol Chem."},{"key":"910_CR58","doi-asserted-by":"crossref","unstructured":"Wu Y, Shi W, Tang T, Wang Y, Yin X, Chen Y, et al. miR-29a contributes to breast cancer cells epithelial-mesenchymal transition, migration, and invasion via down-regulating histone H4K20 trimethylation through directly targeting SUV420H2. Cell Death Dis. 2019a; 10: 856.","DOI":"10.1038\/s41419-019-1437-0"},{"key":"910_CR59","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1158\/1541-7786.MCR-17-0688","volume":"16","author":"KL Paquin","year":"2018","unstructured":"Paquin KL, Howlett NG. Understanding the histone DNA repair code: H4K20me2 makes its mark. Mol Cancer Res. 2018;16:1335\u201345.","journal-title":"Mol Cancer Res."},{"key":"910_CR60","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.celrep.2017.09.086","volume":"21","author":"R Domaschenz","year":"2017","unstructured":"Domaschenz R, Kurscheid S, Nekrasov M, Han S, Tremethick DJ. The histone variant H2A.Z is a master regulator of the epithelial-mesenchymal transition. Cell Rep. 2017;21:943\u201352.","journal-title":"Cell Rep."},{"key":"910_CR61","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.molcel.2015.05.009","volume":"59","author":"C Vardabasso","year":"2015","unstructured":"Vardabasso C, Gaspar-Maia A, Hasson D, P\u00fcnzeler S, Valle-Garcia D, Straub T, et al. Histone variant H2A.Z.2 mediates proliferation and drug sensitivity of malignant melanoma. Mol Cell. 2015;59:75\u201388.","journal-title":"Mol Cell."},{"key":"910_CR62","doi-asserted-by":"crossref","unstructured":"Venza M, Visalli M, Biondo C, Lentini M, Catalano T, Teti D, et al. Epigenetic regulation of P14ARF and P16INK4A expression in cutaneous and uveal melanoma. Biochim. Biophys. Acta. 2015; 1849, 247\u2013256.","DOI":"10.1016\/j.bbagrm.2014.12.004"},{"key":"910_CR63","doi-asserted-by":"publisher","first-page":"20160284","DOI":"10.1098\/rstb.2016.0284","volume":"372","author":"S Dhar","year":"2017","unstructured":"Dhar S, Gursoy-Yuzugullu O, Parasuram R, Price BD. The tale of a tail: histone H4 acetylation and the repair of DNA breaks. Philos Trans R Soc Lond B Biol Sci. 2017;372:20160284.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"910_CR64","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1534\/genetics.114.172874","volume":"199","author":"BJ Guppy","year":"2015","unstructured":"Guppy BJ, McManus KJ. Mitotic accumulation of dimethylated lysine 79 of histone H3 is important for maintaining genome integrity during mitosis in human cells. Genetics. 2015;199:423\u201333.","journal-title":"Genetics."},{"key":"910_CR65","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41467-017-02687-7","volume":"9","author":"B Zhu","year":"2018","unstructured":"Zhu B, Chen S, Wang H, Yin C, Han C, Peng C, et al. The protective role of DOT1L in UV-induced melanomagenesis. Nat Commun. 2018;9:259.","journal-title":"Nat Commun."},{"key":"910_CR66","doi-asserted-by":"publisher","first-page":"8225","DOI":"10.1007\/s13277-014-2098-3","volume":"35","author":"A Uzdensky","year":"2014","unstructured":"Uzdensky A, Demyanenko S, Bibov M, Sharifulina S, Kit O, Przhedetski Y, et al. Expression of proteins involved in epigenetic regulation in human cutaneous melanoma and peritumoral skin. Tumour Biol. 2014;35:8225\u201333.","journal-title":"Tumour Biol."},{"key":"910_CR67","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1097\/DAD.0b013e31828a2d54","volume":"37","author":"P Kampilafkos","year":"2015","unstructured":"Kampilafkos P, Melachrinou M, Kefalopoulou Z, Lakoumentas J, Sotiropoulou-Bonikou G. Epigenetic modifications in cutaneous malignant melanoma: EZH2, H3K4me2, and H3K27me3 immunohistochemical expression is enhanced at the invasion front of the tumor. Am J Dermatopathol. 2015;37:138\u201344.","journal-title":"Am J Dermatopathol."},{"key":"910_CR68","doi-asserted-by":"crossref","unstructured":"Ha\u0142asa M, Wawruszak A, Przybyszewska A, Jaruga A, Guz M, Ka\u0142afut J, et al. H3K18Ac as a marker of cancer progression and potential target of anti-cancer therapy. Cells. 2019;8:485.","DOI":"10.3390\/cells8050485"},{"key":"910_CR69","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13148-019-0645-x","volume":"11","author":"QL Li","year":"2019","unstructured":"Li QL, Wang DY, Ju LG, Yao J, Gao C, Lei PJ, et al. The hyper-activation of transcriptional enhancers in breast cancer. Clin Epigenetics. 2019;11:48.","journal-title":"Clin Epigenetics."},{"key":"910_CR70","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.ejso.2013.02.023","volume":"39","author":"H Tamagawa","year":"2013","unstructured":"Tamagawa H, Oshima T, Numata M, Yamamoto N, Shiozawa M, Morinaga S, et al. Global histone modification of H3K27 correlates with the outcomes in patients with metachronous liver metastasis of colorectal cancer. Eur J Surg Oncol. 2013;39:655\u201361.","journal-title":"Eur J Surg Oncol."},{"key":"910_CR71","doi-asserted-by":"crossref","unstructured":"Yuan S, Natesan R, Sanchez-Rivera FJ, Li J, Bhanu NV, Yamazoe T, et al. Global regulation of the histone mark H3K36me2 underlies epithelial plasticity and metastatic progression. Cancer Discov. 2020; CD-19-1299.","DOI":"10.1158\/2159-8290.CD-19-1299"},{"key":"910_CR72","doi-asserted-by":"publisher","first-page":"5699","DOI":"10.1038\/onc.2015.24","volume":"34","author":"N Kanu","year":"2015","unstructured":"Kanu N, Gr\u00f6nroos E, Martinez P, Burrell RA, Yi Goh X, Bartkova J, et al. SETD2 loss-of-function promotes renal cancer branched evolution through replication stress and impaired DNA repair. Oncogene. 2015;34:5699\u2013708.","journal-title":"Oncogene."},{"key":"910_CR73","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1002\/ijc.2910390324","volume":"39","author":"DC Bennett","year":"1987","unstructured":"Bennett DC, Cooper PJ, Hart IR. A line of non-tumorigenic mouse melanocytes, syngeneic with the B16 melanoma and requiring a tumour promoter for growth. Int J Cancer. 1987;39:414\u20138.","journal-title":"Int J Cancer."},{"key":"910_CR74","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15\u201321.","journal-title":"Bioinformatics."},{"key":"910_CR75","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkt214","volume":"41","author":"Y Liao","year":"2013","unstructured":"Liao Y, Smyth GK, Shi W. The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote. Nucleic Acids Research. 2013;41:e108.","journal-title":"Nucleic Acids Research."},{"key":"910_CR76","doi-asserted-by":"crossref","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Research. 2015; 43: e47.","DOI":"10.1093\/nar\/gkv007"},{"key":"910_CR77","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.","journal-title":"BMC Bioinformatics."},{"issue":"7","key":"910_CR78","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","volume":"161","author":"CGA Network","year":"2015","unstructured":"Network CGA. Genomic classification of cutaneous melanoma. Cell. 2015;161(7):1681\u201396.","journal-title":"Cell."},{"key":"910_CR79","doi-asserted-by":"crossref","unstructured":"Nsengimana J, Laye J, Filia A, O'Shea S, Muralidhar S, Po\u017aniak J, et al. \u03b2-Catenin-mediated immune evasion pathway frequently operates in primary cutaneous melanomas. J Clin Invest. 2018; 128: 2048-2063.","DOI":"10.1172\/JCI95351"},{"key":"910_CR80","doi-asserted-by":"publisher","first-page":"W589","DOI":"10.1093\/nar\/gkv350","volume":"43","author":"D Smedley","year":"2015","unstructured":"Smedley D, Haider S, Durinck S, Pandini L, Provero P, Allen J, et al. The BioMart community portal: an innovative alternative to large, centralized data repositories. Nucleic Acids Res. 2015;43:W589\u201398.","journal-title":"Nucleic Acids Res."},{"key":"910_CR81","doi-asserted-by":"publisher","first-page":"17314","DOI":"10.1038\/s41598-017-17330-0","volume":"7","author":"R Metri","year":"2017","unstructured":"Metri R, Mohan A, Nsengimana J, Pozniak J, Molina-Paris C, Newton-Bishop J, et al. Identification of a gene signature for discriminating metastatic from primary melanoma using a molecular interaction network approach. Sci. Rep. 2017;7:17314.","journal-title":"Sci. Rep."},{"key":"910_CR82","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov MV, Jones MR, Rouillard AD, Fernandez NF, Duan Q, Wang Z, et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44:W90\u20137.","journal-title":"Nucleic Acids Res."},{"key":"910_CR83","doi-asserted-by":"crossref","unstructured":"ENCODE Project Consortium. A user\u2019s guide to the encyclopedia of DNA elements (ENCODE). PLoS Biol. 2011; 9: e1001046.","DOI":"10.1371\/journal.pbio.1001046"},{"key":"910_CR84","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41392-019-0095-0","volume":"4","author":"Y Cheng","year":"2019","unstructured":"Cheng Y, He C, Wang M, Ma X, Mo F, Yang S, et al. Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials. Signal Transduct Target Ther. 2019;4:62.","journal-title":"Signal Transduct Target Ther."},{"key":"910_CR85","doi-asserted-by":"publisher","first-page":"11448","DOI":"10.1021\/acs.analchem.5b03009","volume":"87","author":"S Sidoli","year":"2015","unstructured":"Sidoli S, Simithy J, Karch KR, Kulej K, Garcia BA. Low resolution data-independent acquisition in an LTQ-Orbitrap allows for simplified and fully untargeted analysis of histone modifications. Analytical chemistry. 2015;87:11448\u201354.","journal-title":"Analytical chemistry."},{"key":"910_CR86","doi-asserted-by":"crossref","unstructured":"Sidoli S, Bhanu NV, Karch KR, Wang X, Garcia BA. Complete workflow for analysis of histone post-translational modifications using bottom-up mass spectrometry: from histone extraction to data analysis. Journal of visualized experiments: JoVE. 2016;111.","DOI":"10.3791\/54112"},{"key":"910_CR87","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1021\/acs.jproteome.8b00133","volume":"17","author":"ZF Yuan","year":"2018","unstructured":"Yuan ZF, Sidoli S, Marchione DM, Simithy J, Janssen KA, Szurgot MR, et al. EpiProfile 2.0: a computational platform for processing epi-proteomics mass spectrometry data. Journal of proteome research. 2018;17:2533\u201341.","journal-title":"Journal of proteome research."}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-020-00910-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-020-00910-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-020-00910-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,17]],"date-time":"2022-04-17T21:04:17Z","timestamp":1650229457000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalepigeneticsjournal.biomedcentral.com\/articles\/10.1186\/s13148-020-00910-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,24]]},"references-count":87,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["910"],"URL":"https:\/\/doi.org\/10.1186\/s13148-020-00910-9","relation":{},"ISSN":["1868-7075","1868-7083"],"issn-type":[{"value":"1868-7075","type":"print"},{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,24]]},"assertion":[{"value":"9 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"127"}}